BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

551 related articles for article (PubMed ID: 16780977)

  • 1. Clinical experience with the MammoSite radiation therapy system for brachytherapy of breast cancer: results from an international phase II trial.
    Niehoff P; Polgár C; Ostertag H; Major T; Sulyok Z; Kimmig B; Kovács G
    Radiother Oncol; 2006 Jun; 79(3):316-20. PubMed ID: 16780977
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Early European experience with the MammoSite radiation therapy system for partial breast brachytherapy following breast conservation operation in low-risk breast cancer.
    Niehoff P; Ballardini B; Polgár C; Major T; Hammer J; Richetti A; Kovács G
    Breast; 2006 Jun; 15(3):319-25. PubMed ID: 16765284
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Preliminary results and evaluation of MammoSite balloon brachytherapy for partial breast irradiation for pure ductal carcinoma in situ: a phase II clinical study.
    Benitez PR; Streeter O; Vicini F; Mehta V; Quiet C; Kuske R; Hayes MK; Arthur D; Kuerer H; Freedman G; Keisch M; Dipetrillo T; Khan D; Hudes R
    Am J Surg; 2006 Oct; 192(4):427-33. PubMed ID: 16978943
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Five-year results: the initial clinical trial of MammoSite balloon brachytherapy for partial breast irradiation in early-stage breast cancer.
    Benitez PR; Keisch ME; Vicini F; Stolier A; Scroggins T; Walker A; White J; Hedberg P; Hebert M; Arthur D; Zannis V; Quiet C; Streeter O; Silverstein M
    Am J Surg; 2007 Oct; 194(4):456-62. PubMed ID: 17826055
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Accelerated partial breast irradiation via the mammosite catheter: preliminary reports of a single-institution experience.
    Guenzi M; Giannelli F; Azinwi C; Ricchetti F; Vagge S; Canavese G; Massa T; Garelli S; Carli F; Corvò R
    Breast J; 2009; 15(6):603-9. PubMed ID: 19995379
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Acute complications of MammoSite brachytherapy: a single institution's initial clinical experience.
    Harper JL; Jenrette JM; Vanek KN; Aguero EG; Gillanders WE
    Int J Radiat Oncol Biol Phys; 2005 Jan; 61(1):169-74. PubMed ID: 15629608
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Acute toxicity of high-dose-rate intracavitary brachytherapy with the MammoSite applicator in patients with early-stage breast cancer.
    Richards GM; Berson AM; Rescigno J; Sanghavi S; Siegel B; Axelrod D; Bernik S; Scarpinato V; Mills C
    Ann Surg Oncol; 2004 Aug; 11(8):739-46. PubMed ID: 15249336
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Partial breast irradiation as sole therapy for low risk breast carcinoma: early toxicity, cosmesis and quality of life results of a MammoSite brachytherapy phase II study.
    Belkacémi Y; Chauvet MP; Giard S; Villette S; Lacornerie T; Bonodeau F; Baranzelli MC; Bonneterre J; Lartigau E
    Radiother Oncol; 2009 Jan; 90(1):23-9. PubMed ID: 18692927
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Analysis of treatment efficacy, cosmesis, and toxicity using the MammoSite breast brachytherapy catheter to deliver accelerated partial-breast irradiation: the william beaumont hospital experience.
    Chao KK; Vicini FA; Wallace M; Mitchell C; Chen P; Ghilezan M; Gilbert S; Kunzman J; Benitez P; Martinez A
    Int J Radiat Oncol Biol Phys; 2007 Sep; 69(1):32-40. PubMed ID: 17467920
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cosmetic outcome and incidence of infection with the MammoSite breast brachytherapy applicator.
    Dickler A; Kirk MC; Choo J; Hsi WC; Chu J; Dowlatshahi K; Francescatti D; Shott S; Nguyen C
    Breast J; 2005; 11(5):306-10. PubMed ID: 16174149
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MammoSite accelerated partial breast irradiation: a single-institution outcomes analysis with 2 years of followup.
    Haley M; Beriwal S; Heron DE; Kim H; Falk J; Johnson R; Mogus R
    Brachytherapy; 2009; 8(1):9-13. PubMed ID: 18955020
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High-dose-rate (HDR) or pulsed-dose-rate (PDR) perioperative interstitial intensity-modulated brachytherapy (IMBT) for local recurrences of previously irradiated breast or thoracic wall following breast cancer.
    Niehoff P; Dietrich J; Ostertag H; Schmid A; Kohr P; Kimmig B; Kovács G
    Strahlenther Onkol; 2006 Feb; 182(2):102-7. PubMed ID: 16447017
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Phase I/II study evaluating early tolerance in breast cancer patients undergoing accelerated partial breast irradiation treated with the mammosite balloon breast brachytherapy catheter using a 2-day dose schedule.
    Wallace M; Martinez A; Mitchell C; Chen PY; Ghilezan M; Benitez P; Brown E; Vicini F
    Int J Radiat Oncol Biol Phys; 2010 Jun; 77(2):531-6. PubMed ID: 19775830
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Partial breast irradiation with interstitial 60CO brachytherapy results in frequent grade 3 or 4 toxicity. Evidence based on a 12-year follow-up of 70 patients.
    Póti Z; Nemeskéri C; Fekésházy A; Sáfrány G; Bajzik G; Nagy ZP; Bidlek M; Sinkovics I; Udvarhelyi N; Liszkay G; Repa I; Galuska L; Trón L; Mayer A; Esik O
    Int J Radiat Oncol Biol Phys; 2004 Mar; 58(4):1022-33. PubMed ID: 15001241
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Descriptions and outcomes of insertion techniques of a breast brachytherapy balloon catheter in 1403 patients enrolled in the American Society of Breast Surgeons MammoSite breast brachytherapy registry trial.
    Zannis V; Beitsch P; Vicini F; Quiet C; Keleher A; Garcia D; Snider H; Gittleman M; Kuerer H; Whitacre E; Whitworth P; Fine R; Haffty B; Stolier A; Mabie J
    Am J Surg; 2005 Oct; 190(4):530-8. PubMed ID: 16164915
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment volume and dose optimization of MammoSite breast brachytherapy applicator.
    Dickler A; Kirk M; Choo J; Hsi WC; Chu J; Dowlatshahi K; Francescatti D; Nguyen C
    Int J Radiat Oncol Biol Phys; 2004 Jun; 59(2):469-74. PubMed ID: 15145164
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The MammoSite breast brachytherapy applicator: a review of technique and outcomes.
    Dickler A; Kirk MC; Chu J; Nguyen C
    Brachytherapy; 2005; 4(2):130-6. PubMed ID: 15893266
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Multi-institutional experience using the MammoSite radiation therapy system in the treatment of early-stage breast cancer: 2-year results.
    Cuttino LW; Keisch M; Jenrette JM; Dragun AE; Prestidge BR; Quiet CA; Vicini FA; Rescigno J; Wazer DE; Kaufman SA; Ramakrishnan VR; Patel R; Arthur DW
    Int J Radiat Oncol Biol Phys; 2008 May; 71(1):107-14. PubMed ID: 18037585
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Accelerated partial breast irradiation: an analysis of variables associated with late toxicity and long-term cosmetic outcome after high-dose-rate interstitial brachytherapy.
    Wazer DE; Kaufman S; Cuttino L; DiPetrillo T; Arthur DW
    Int J Radiat Oncol Biol Phys; 2006 Feb; 64(2):489-95. PubMed ID: 16246495
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The use of the source-skin distance measuring bridge indeed reduces skin teleangiectasia after interstitial boost in breast conserving therapy.
    Georg P; Georg D; Van Limbergen E
    Radiother Oncol; 2005 Mar; 74(3):323-30. PubMed ID: 15763314
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 28.